Near Space Labs, a leading innovator in stratospheric robotics and Earth observation technology, announced that Tom Chi, founding member of Google X and former head of Project Loon, has joined the company as a strategic investor and board observer. Chi’s…
Copyright Clearance Center (CCC), a global pioneer in voluntary collective licensing and information management solutions, has announced a new collaboration with the China Educational Publications Import & Export Corporation (CEPIEC). CEPIEC is the leading distributor of international scholarly content to…
Merz Therapeutics GmbH, a global leader in neurology-focused specialty pharmaceuticals, today announced the opening of its new affiliate in Warsaw, Poland. This strategic expansion marks a major milestone in the company’s ongoing global growth and underlines its long-term commitment to…
Tidepool, a leading nonprofit innovator in the diabetes technology space, has announced its inclusion as an inaugural member of the Milken Institute’s Women’s Health Network. The milestone marks a significant step forward in recognizing the critical intersection between women’s health…
Aphios Corporation, a leading innovator in botanical pharmaceuticals, green chemistry, and biotechnology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Center for Complementary & Integrative Health (NCCIH) at the…
bioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, announced record sales growth for its flagship diagnostic test, CyPath®…
Veristat, a global clinical research organization (CRO) and consultancy specializing in complex clinical studies, announced its participation in the upcoming Clinical Outsourcing Group (COG) – Bay Area 2025 conference, to be held October 21–22, 2025, at the Hyatt Regency San…
AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing proprietary nebulized combination therapies for chronic respiratory diseases, announced the successful closing of a $21 million Series A financing. The funding round was led by Avalon BioVentures, with additional participation…
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration with the University of British Columbia (UBC). This partnership aims to accelerate the discovery and development of novel antibody…
RevBio, Inc., a developer of regenerative biomaterials for bone repair, announced it has received a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), a division of the National Institutes of Health…